Multi-year investment reinforces U.S. business expansion and adds to $7 billion in U.S. pharma R&D and manufacturing ...

Ayush services economy could scale to US $216–318 billion by 2047 subject to the strengthening of infrastructure, quality ...

Zealand Pharma’s investigational obesity drug survodutide delivered sustained weight loss and improved blood sugar control in ...

The data tracked patients for up to two years and found that the safety profile of LEQSELVI remained generally consistent ...

Eli Lilly has claimed that new analyses of its once-daily oral GLP-1 drug Foundayo (orforglipron) showed substantial reductions in predicted 10-year risks of type 2 diabetes and cardiovascular disease ...

Overall survival data remain immature, although the study showed a positive trend in both the overall population and the ESR1-mutated subgroup ...

Moderna is creating a new Chief Operating Officer role as the biotech prepares to scale its oncology business, expand manufacturing and manage a growing portfolio of vaccines. Juan Andres will return ...

Eli Lilly and Company, maker of Zepbound (tirzepatide) and Foundayo (orforglipron), has said that its investigational drug ...

The partnership will bring together Apollo’s clinical ecosystem with BITS Pilani’s expertise in engineering, technology and ...

The filing seeks approval of fenebrutinib for adults with relapsing multiple sclerosis (RMS) and primary progressive multiple ...

French biotechnology company Abolis Biotechnologies has launched MINE (Microbial INtelligence Explorer), a new ...

The initiative will target hospitals, diagnostic centres, research institutions and smaller healthcare facilities ...